chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination complication
Clinical narrative: Still having symptoms; Severe joint pain; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION COMPLICATION (Still having symptoms) and ARTHRALGIA (Severe joint pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced ARTHRALGIA (Severe joint pain). On an unknown date, the patient experienced VACCINATION COMPLICATION (Still having symptoms). At the time of the report, VACCINATION COMPLICATION (Still having symptoms) and ARTHRALGIA (Severe joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. Treatment medication included Tylenol.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Gait disturbance, Joint swelling, Peripheral swelling
Clinical narrative: Not able to walk; Knees very weak; Knees very swollen; Swollen in the legs; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (Not able to walk), ASTHENIA (Knees very weak), JOINT SWELLING (Knees very swollen) and PERIPHERAL SWELLING (Swollen in the legs) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, Heart disease, unspecified, Overweight, Osteoporosis and Arthritis.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced GAIT DISTURBANCE (Not able to walk), ASTHENIA (Knees very weak), JOINT SWELLING (Knees very swollen) and PERIPHERAL SWELLING (Swollen in the legs). At the time of the report, GAIT DISTURBANCE (Not able to walk), ASTHENIA (Knees very weak), JOINT SWELLING (Knees very swollen) and PERIPHERAL SWELLING (Swollen in the legs) outcome was unknown.            Products known to have been used by the patient, within two weeks prior to the event , included blood pressure medications and heart medications.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-059390 (E2B Linked Report).; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product. US-MODERNATX, INC.-MOD-2021-059390:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: headache; fever; A spontaneous report was received from a consumer concerning herself, who is a 37-years-old female patient received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache, fever.  The patient's medical history was not provided. Concomitant medications reported were sometimes sleeping pills.  On 2 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 012A21A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 2 Mar 2021, the patient experienced the events headache, fever.  Treatment for the events includes aspirin/paracetamol/caffeine and estazolam.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events headache, fever was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever now at 101 degrees; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever) and PYREXIA (Fever now at 101 degrees) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 042L20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included LEVOTHYROXINE, METFORMIN and INSULIN for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Low grade fever). On 12-Feb-2021, the patient experienced PYREXIA (Fever now at 101 degrees). At the time of the report, PYREXIA (Low grade fever) and PYREXIA (Fever now at 101 degrees) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Body temperature: 101 f High.         Treatment medications were not provided by reporter.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Vaccination site pain
Clinical narrative: arm was a little sore at the injection site; not able to sleep on left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm got pretty sore), INSOMNIA (not able to sleep on left side) and VACCINATION SITE PAIN (arm was a little sore at the injection site) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (arm got pretty sore) and INSOMNIA (not able to sleep on left side). On an unknown date, the patient experienced VACCINATION SITE PAIN (arm was a little sore at the injection site). In February 2021, PAIN IN EXTREMITY (arm got pretty sore) and INSOMNIA (not able to sleep on left side) outcome was unknown. At the time of the report, VACCINATION SITE PAIN (arm was a little sore at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Treatment information was not provided.   This case was linked to MOD-2021-241651 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow up information received on 30 Jun 2021. New event added.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling cold, Feeling hot, Headache, Vaccination site discolouration
Clinical narrative: pink spot IS; Dizzy; Headache; "hot inside"; "cold outside"; "big red spot" IS; Itch "like hell" IS; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN ("big red spot" IS), VACCINATION SITE PRURITUS (Itch "like hell" IS), FEELING HOT ("hot inside"), FEELING COLD ("cold outside") and DIZZINESS (Dizzy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (NO HISTORICAL CONDITION REPORTED.).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE PAIN ("big red spot" IS) and VACCINATION SITE PRURITUS (Itch "like hell" IS). On 25-Feb-2021, the patient experienced FEELING HOT ("hot inside") and FEELING COLD ("cold outside"). On 28-Feb-2021, the patient experienced DIZZINESS (Dizzy) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (pink spot IS). At the time of the report, VACCINATION SITE PAIN ("big red spot" IS), VACCINATION SITE PRURITUS (Itch "like hell" IS), FEELING HOT ("hot inside"), FEELING COLD ("cold outside"), DIZZINESS (Dizzy), HEADACHE (Headache) and VACCINATION SITE DISCOLOURATION (pink spot IS) outcome was unknown.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus
Clinical narrative: pink spot IS; Dizzy; Headache; "hot inside"; "cold outside"; "big red spot" IS; Itch "like hell" IS; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN ("big red spot" IS), VACCINATION SITE PRURITUS (Itch "like hell" IS), FEELING HOT ("hot inside"), FEELING COLD ("cold outside") and DIZZINESS (Dizzy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (NO HISTORICAL CONDITION REPORTED.).    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE PAIN ("big red spot" IS) and VACCINATION SITE PRURITUS (Itch "like hell" IS). On 25-Feb-2021, the patient experienced FEELING HOT ("hot inside") and FEELING COLD ("cold outside"). On 28-Feb-2021, the patient experienced DIZZINESS (Dizzy) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (pink spot IS). At the time of the report, VACCINATION SITE PAIN ("big red spot" IS), VACCINATION SITE PRURITUS (Itch "like hell" IS), FEELING HOT ("hot inside"), FEELING COLD ("cold outside"), DIZZINESS (Dizzy), HEADACHE (Headache) and VACCINATION SITE DISCOLOURATION (pink spot IS) outcome was unknown.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site warmth, Pain
Clinical narrative: Burning; hot; Pain; A spontaneous report was received from a consumer concerning a 80-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events burning(Injection site pain), hot(Injection site warmth ), pain(Pain).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 01 Mar 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (batch number: 029120A) intramuscularly for prophylaxis of COVID-19 infection.   On 03 Mar 2021, the patient experienced the event(s) burning, hot, pain.  Treatment details included Ice pack, heating pad, Tylenol.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of the event(s), burning, hot, pain was unknown.
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Pruritus
Clinical narrative: itchy; beat red on side of abdominal; fatigue; beat red on chest; A spontaneous report was received from a consumer concerning a 91-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events beat red on chest/erythema, fatigue, beat red on side of abdominal/erythema, itchy/pruritus.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 011M21A) intramuscularly for prophylaxis of COVID-19 infection.  On 2 Mar 2021, the patient experienced the events, beat red on chest, fatigue. On 3 Mar 2021, the patient experienced the event(s) beat red on side of abdominal, itchy.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, beat red on chest, fatigue, beat red on side of abdominal, itchy was unknown.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Administered 1ml instead of 0.5ml) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 milliliter. On 01-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (Administered 1ml instead of 0.5ml). On 01-Mar-2021, ACCIDENTAL OVERDOSE (Administered 1ml instead of 0.5ml) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication and treatment information were not reported.   This case was linked to MOD-2021-033777, US-MODERNATX, INC.-MOD-2021-033777 (E2B Linked Report).; Sender's Comments:  MOD-2021-033777:Crosslinked case US-MODERNATX, INC.-MOD-2021-033777:Crosslink case
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pruritus
Clinical narrative: Hard to breathe; Itching on feet; Itching on bumps; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Hard to breathe), PRURITUS (Itching on feet) and PRURITUS (Itching on bumps) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS. Concomitant products included ROPINIROLE HYDROCHLORIDE (REQUIP) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced DYSPNOEA (Hard to breathe), PRURITUS (Itching on feet) and PRURITUS (Itching on bumps). At the time of the report, DYSPNOEA (Hard to breathe), PRURITUS (Itching on feet) and PRURITUS (Itching on bumps) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication included Benadryl.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: followup received on 30-apr-2021:reporter contact information was added
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: a little rash on the shoulder of the arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of RASH (a little rash on the shoulder of the arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012M20A) for COVID-19 vaccination.     Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) and CALCIUM for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jan-2021, the patient experienced RASH (a little rash on the shoulder of the arm). At the time of the report, RASH (a little rash on the shoulder of the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.   This case was linked to MOD-2021-218922 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pollakiuria, Vulvovaginal pruritus
Clinical narrative: excessive itching in her vagina; Urinating more than normal; This spontaneous case was reported by a consumer and describes the occurrence of VULVOVAGINAL PRURITUS (excessive itching in her vagina) and POLLAKIURIA (Urinating more than normal) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced VULVOVAGINAL PRURITUS (excessive itching in her vagina) and POLLAKIURIA (Urinating more than normal). On 07-Feb-2021, VULVOVAGINAL PRURITUS (excessive itching in her vagina) and POLLAKIURIA (Urinating more than normal) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Mobility decreased, Pain, Peripheral swelling, Rash
Clinical narrative: Patient's left arm was swollen; Patient noticed fever sores under her nose and around her lips; (left arm) red; (left arm) rash all the way to the wrist; she couldn't get out of bed; Patient was so much in pain; A spontaneous report was received from a consumer concerning a 78-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events patient was so much in pain, patient's left arm was swollen, patient noticed fever sores under her nose and around her lips, she couldn't get out of bed, (left arm) red, (left arm) rash all the way to the wrist,  The patient's medical history was not provided. Concomitant medications reported were Symbicort, Calcium, Vitamin D for drug use for unknown indication.  On 26 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 016A21A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 27 Feb 2021, the patient experienced the event(s) patient was so much in pain. On 28 Feb 2021, the patient experienced the event(s) patient's left arm was swollen, patient noticed fever sores under her nose and around her lips, she couldn't get out of bed, (left arm) red, (left arm) rash all the way to the wrist. On an unknown date, the patient experienced the event(s) .  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), patient was so much in pain, patient's left arm was swollen, patient noticed fever sores under her nose and around her lips, she couldn't get out of bed, (left arm) red, (left arm) rash all the way to the wrist,  was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Patient's left arm was swollen; Patient noticed fever sores under her nose and around her lips; (left arm) red; (left arm) rash all the way to the wrist; she couldn't get out of bed; Patient was so much in pain; A spontaneous report was received from a consumer concerning a 78-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events patient was so much in pain, patient's left arm was swollen, patient noticed fever sores under her nose and around her lips, she couldn't get out of bed, (left arm) red, (left arm) rash all the way to the wrist,  The patient's medical history was not provided. Concomitant medications reported were Symbicort, Calcium, Vitamin D for drug use for unknown indication.  On 26 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 016A21A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 27 Feb 2021, the patient experienced the event(s) patient was so much in pain. On 28 Feb 2021, the patient experienced the event(s) patient's left arm was swollen, patient noticed fever sores under her nose and around her lips, she couldn't get out of bed, (left arm) red, (left arm) rash all the way to the wrist. On an unknown date, the patient experienced the event(s) .  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), patient was so much in pain, patient's left arm was swollen, patient noticed fever sores under her nose and around her lips, she couldn't get out of bed, (left arm) red, (left arm) rash all the way to the wrist,  was unknown.
Age: 60.0
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash (L) and (R) arms; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash (L) and (R) arms) in a 60-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030120A) for COVID-19 vaccination.     The patient's past medical history included Immune disorder (NOS).   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (rash (L) and (R) arms). At the time of the report, RASH (rash (L) and (R) arms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Lymph node pain, Pruritus, Skin reaction
Clinical narrative: Lymph nodes feel like bee stings; Tired; Red arm; Itchy arm; COVID Arm; A spontaneous report was received from a consumer concerning a 67-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tired, lymph nodes feel like bee stings, itchy arm, red covid arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 23 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (batch: 030M20A )in left non-dominant arm for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the events tired, lymph nodes feel like bee stings, 7 days after receiving the first shot now has itchy red COVID Arm. Patient consented to Safety follow-up.   No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported.  The outcome of events tired, lymph nodes feel like bee stings, itchy arm, red covid arm were unknown.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersomnia, Lymphadenopathy
Clinical narrative: were sleeping a ton; lymph nodes in armpit and neck were inflammed; had headaches; A spontaneous report was received from a healthcare professional concerning a 43-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events had headaches, were sleeping a ton/hypersomnia, lymph nodes in armpit and neck were inflamed/lymphadenopathy.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 15 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 012L20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  On 15 Jan 2021, the patient experienced the event(s) had headaches.  On an unknown date, the patient experienced the events, were sleeping a ton, lymph nodes in armpit and neck were inflamed.  On 12 Feb 2021, the patient received their second of two planned doses of mRNA-1273 (lot/batch: 030L20A) via unknown route in the left arm for prophylaxis of COVID-19 infection.  Treatment details included Advill.  The patient received both the doses of mRNA-1273  prior to the events, therefore action taken against the drug in response to the events was not applicable.  The outcome of event, had headaches, was resolved on 18 Jan 2021.  The outcome of events, were sleeping a ton, lymph nodes in armpit and neck were inflamed was unknown
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation
Clinical narrative: Burning sensation in his leg; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning sensation in his leg) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced BURNING SENSATION (Burning sensation in his leg). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BURNING SENSATION (Burning sensation in his leg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medications are provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site swollen; Injection site sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE PAIN (Injection site sore) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE PAIN (Injection site sore). The patient was treated with LISINOPRIL ongoing since an unknown date at a dose of 1 dosage form; NAPROXEN SODIUM (ALEVE) at a dose of 1 dosage form and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE SWELLING (Injection site swollen) and VACCINATION SITE PAIN (Injection site sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided by reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain, Vaccination site swelling
Clinical narrative: right arm extremely swollen; right arm really sore; felt really tired, need to go to bed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (right arm really sore), FATIGUE (felt really tired, need to go to bed) and VACCINATION SITE SWELLING (right arm extremely swollen) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Allergy.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced VACCINATION SITE PAIN (right arm really sore) and FATIGUE (felt really tired, need to go to bed). On 01-Mar-2021, the patient experienced VACCINATION SITE SWELLING (right arm extremely swollen). The patient was treated with IBUPROFEN at a dose of 1 dosage form twice a day. At the time of the report, VACCINATION SITE PAIN (right arm really sore), FATIGUE (felt really tired, need to go to bed) and VACCINATION SITE SWELLING (right arm extremely swollen) outcome was unknown.            no concomitant medications are provided. Action taken with mRNA-1273 in response to the event was not applicable
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test positive, Ultrasound abdomen
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 35-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Alcohol abuse (5 drinks a weak.). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from January 2021 to an unknown date and PARACETAMOL (TYLENOL) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 14-Dec-2020 and the estimated date of delivery was 20-Sep-2021. On 03-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  eleventh week of the pregnancy.  On 03-Mar-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Pregnancy test positive: positive Positive. On 16-Jan-2021, Ultrasound abdomen: normal normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. Patient would like to register for the pregnancy registry.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Injection site was red; swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Injection site was red) and VACCINATION SITE SWELLING (swollen) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-1939, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site was red) and VACCINATION SITE SWELLING (swollen). At the time of the report, VACCINATION SITE ERYTHEMA (Injection site was red) and VACCINATION SITE SWELLING (swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Soreness in my shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Soreness in my shoulder) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced ARTHRALGIA (Soreness in my shoulder). At the time of the report, ARTHRALGIA (Soreness in my shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concomitant products included LOSARTAN, ATORVASTATIN, PANTOPRAZOLE, HYDROCHLOROTHIAZIDE, CLOPIDOGREL, AMLODIPINE and ALLOPURINOL for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms). On 05-Feb-2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Concomitant medications also included OTC allergy relief and low dose aspirin.   This case was linked to US-MODERNATX, INC.-MOD-2021-034711 (Linked Report). This case was linked to MOD-2021-100039 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-034711:Wife's case
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Limb discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: Arm was heavy and Could not lift arm; Arm was swollen; Arm painful; Chills; Extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm was heavy and Could not lift arm), PERIPHERAL SWELLING (Arm was swollen), PAIN IN EXTREMITY (Arm painful), CHILLS (Chills) and FATIGUE (Extreme fatigue) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 28l201a) for COVID-19 vaccination.     No medical history information was provided by reporter.  Concomitant products included CHOLESTEROL for an unknown indication.    On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced LIMB DISCOMFORT (Arm was heavy and Could not lift arm), PERIPHERAL SWELLING (Arm was swollen), PAIN IN EXTREMITY (Arm painful), CHILLS (Chills) and FATIGUE (Extreme fatigue). On 12-Feb-2021, LIMB DISCOMFORT (Arm was heavy and Could not lift arm), PERIPHERAL SWELLING (Arm was swollen), PAIN IN EXTREMITY (Arm painful), CHILLS (Chills) and FATIGUE (Extreme fatigue) had resolved.            Treatment medications were not provided by reporter.  Patient stated that she had lymphedema in her left arm.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021 contains non significant information. The reporter contact details were updated.
Sex: M
Vaccine: COVID19
Symptoms: Insomnia, Pharyngeal swelling
Clinical narrative: Swollen throat; Troubled sleeping; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (Swollen throat) and INSOMNIA (Troubled sleeping) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced PHARYNGEAL SWELLING (Swollen throat) and INSOMNIA (Troubled sleeping). At the time of the report, PHARYNGEAL SWELLING (Swollen throat) and INSOMNIA (Troubled sleeping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not provided.  Patient declined to give and any other information regarding vaccine or demographic info.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Dizziness, Heart rate, Hypersensitivity
Clinical narrative: Tachycardia; Allergic reaction; Dizziness; High BP; This spontaneous case was reported by a health care professional and describes the occurrence of TACHYCARDIA (Tachycardia), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizziness) and HYPERTENSION (High BP) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypersensitivity reaction (Past allergies).    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced TACHYCARDIA (Tachycardia), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizziness) and HYPERTENSION (High BP). On 29-Dec-2020, TACHYCARDIA (Tachycardia), DIZZINESS (Dizziness) and HYPERTENSION (High BP) had resolved. At the time of the report, HYPERSENSITIVITY (Allergic reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2020, Blood pressure measurement: 174/110 mmhg (High) High. On 29-Dec-2020, Body temperature: 36.6 (normal) Normal. On 29-Dec-2020, Heart rate: 137 (High) High pulse rate. On 29-Dec-2020, Respiratory rate: 20 bpm (normal) Normal. On 08-Jan-2021, Blood pressure measurement: 155/82 mmhg (High) High. On 08-Jan-2021, Body temperature: 37.6 (normal) Normal. On 08-Jan-2021, Heart rate: 123 (High) High. On 08-Jan-2021, Respiratory rate: 19 bpm (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported  Treatment included: Blood pressure medications and oxygen  It was also stated that Tachycardia was the residual effect of the events   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received on 21-JUL-2021 contains: Updated reporter information; Updated patient details; Updated Lab data; Updated Event- Difficulty breathing; Updated Stop dates of events;
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Respiratory rate, Tachycardia
Clinical narrative: Tachycardia; Allergic reaction; Dizziness; High BP; This spontaneous case was reported by a health care professional and describes the occurrence of TACHYCARDIA (Tachycardia), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizziness) and HYPERTENSION (High BP) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypersensitivity reaction (Past allergies).    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced TACHYCARDIA (Tachycardia), HYPERSENSITIVITY (Allergic reaction), DIZZINESS (Dizziness) and HYPERTENSION (High BP). On 29-Dec-2020, TACHYCARDIA (Tachycardia), DIZZINESS (Dizziness) and HYPERTENSION (High BP) had resolved. At the time of the report, HYPERSENSITIVITY (Allergic reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2020, Blood pressure measurement: 174/110 mmhg (High) High. On 29-Dec-2020, Body temperature: 36.6 (normal) Normal. On 29-Dec-2020, Heart rate: 137 (High) High pulse rate. On 29-Dec-2020, Respiratory rate: 20 bpm (normal) Normal. On 08-Jan-2021, Blood pressure measurement: 155/82 mmhg (High) High. On 08-Jan-2021, Body temperature: 37.6 (normal) Normal. On 08-Jan-2021, Heart rate: 123 (High) High. On 08-Jan-2021, Respiratory rate: 19 bpm (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was reported  Treatment included: Blood pressure medications and oxygen  It was also stated that Tachycardia was the residual effect of the events   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received on 21-JUL-2021 contains: Updated reporter information; Updated patient details; Updated Lab data; Updated Event- Difficulty breathing; Updated Stop dates of events;
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Feeling abnormal, Gastrooesophageal reflux disease, Illness
Clinical narrative: felt sick; nausea; acid reflux; migraine; dizziness; brain fog; weakness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt sick), NAUSEA (nausea), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), MIGRAINE (migraine) and DIZZINESS (dizziness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced ILLNESS (felt sick), NAUSEA (nausea), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), MIGRAINE (migraine), DIZZINESS (dizziness), FEELING ABNORMAL (brain fog) and ASTHENIA (weakness). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Migraine, at an unspecified dose and frequency. On 29-Jan-2021, ILLNESS (felt sick), NAUSEA (nausea), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), MIGRAINE (migraine), DIZZINESS (dizziness), FEELING ABNORMAL (brain fog) and ASTHENIA (weakness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea
Clinical narrative: felt sick; nausea; acid reflux; migraine; dizziness; brain fog; weakness; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (felt sick), NAUSEA (nausea), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), MIGRAINE (migraine) and DIZZINESS (dizziness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced ILLNESS (felt sick), NAUSEA (nausea), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), MIGRAINE (migraine), DIZZINESS (dizziness), FEELING ABNORMAL (brain fog) and ASTHENIA (weakness). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Migraine, at an unspecified dose and frequency. On 29-Jan-2021, ILLNESS (felt sick), NAUSEA (nausea), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), MIGRAINE (migraine), DIZZINESS (dizziness), FEELING ABNORMAL (brain fog) and ASTHENIA (weakness) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided
Sex: F
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Adverse Event NOS; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Adverse Event NOS) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Adverse Event NOS). At the time of the report, ADVERSE EVENT (Adverse Event NOS) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment and concomitant medications were not provided by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Adverse event following immunisation
Clinical narrative: side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT FOLLOWING IMMUNISATION (side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT FOLLOWING IMMUNISATION (side effects). At the time of the report, ADVERSE EVENT FOLLOWING IMMUNISATION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported No treatment medications were reported
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pruritus
Clinical narrative: itch on face and arm; sore at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itch on face and arm) and INJECTION SITE PAIN (sore at the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included METHOTREXATE and OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced PRURITUS (itch on face and arm) and INJECTION SITE PAIN (sore at the injection site). At the time of the report, PRURITUS (itch on face and arm) and INJECTION SITE PAIN (sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity, Pyrexia
Clinical narrative: Sore arm; Body ache; Fever; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PAIN (Body ache), FATIGUE (Fatigue) and CHILLS (Chills) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (From November). Concurrent medical conditions included Taste absent (From November). Concomitant products included METOPROLOL, ROSUVASTATIN CALCIUM (CRESTOR), SPIRONOLACTONE and GABAPENTIN for an unknown indication.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), PAIN (Body ache), FATIGUE (Fatigue) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), PAIN (Body ache), FATIGUE (Fatigue) and CHILLS (Chills) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.